Dr. Louise Zhou, MD

Dr. Zhou practices at MultiCare Tacoma General Hospital in Tacoma, Washington, part of MultiCare Health System.

Dr. Zhou's NPI, 1003075490, was assigned on June 2, 2008. Dr. Zhou holds Washington license MD61108658.

Dr. Zhou's primary practice is MultiCare Tacoma General Hospital, at 315 S Mlk Jr Way, Tacoma, WA 98405 in Pierce County. The practice phone is (253) 403-1000.

Dr. Zhou's primary practice is MultiCare Tacoma General Hospital in Tacoma, Washington, part of MultiCare Health System. Dr. Zhou is also affiliated with MultiCare Yakima Memorial Hospital. The medical group on file is MultiCare Indigo Urgent Care, Spokane, Newport Hwy. Dmand AI also links Dr. Zhou to 1 more hospital, 4 medical groups, 1 behavioral health center, 1 group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhou practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Zhou's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zhou is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Zhou's licenses on file in 2 states: Washington and North Carolina.

CMS data shows 387 Medicare services from Dr. Zhou across 6 procedure codes in 2024, for 182 Medicare patients. Medicare paid $31,279 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Dr. Zhou in 2024. The largest group is 75 to 84, with 77 patients. 69% of them have high cholesterol, and 68% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zhou's median patient age at 66, with 56% women.

In 2024, Dr. Zhou wrote 342 Medicare Part D claims for 94 patients. 89% of them were for generic drugs. CMS names the drug for 226 of them, across 10 drugs with 11 or more claims each, at $388,107 in total drug cost. In 2023, CMS named 349 claims across 11 drugs.

Dr. Zhou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhou as offering telehealth.

CMS Open Payments shows 255 general payments to Dr. Zhou from 42 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 93% of the total. Bristol-Myers Squibb Company paid the most, $611.